Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by Stocktreeon Jun 06, 2023 12:02pm
226 Views
Post# 35482585

Facts

FactsYou are dreaming if you think retail SH will get more than a dollar out of this joke of a stock.

This company has a track record of:

- Setting targets they know they will not come close to achieve

- Rewarding management (not employees) for not being close to meeting targets

- Hiding from investors

- Not promoting their stock

- Hiding their stock on a Canadian market

- Not disclosing material information

- Reporting preliminary results as very positive expectations which do not translate into reality (see 2016)

- Sharing information with insiders (SP falling days before out of the blue announcements, CFO selling shares when the SP is rising prior to failed trial results)

- Installing plants like MM to promote the stock on Stockhouse

- Heavily diluting share value by handing out enormous quantities of shares and options

- Giving away assets instead of hard cash managing them

- Not updating their information (see Stockhouse company description)

- Designing a study to leave out 99 percent of sepsis cases while stating their "strict" selection of patients will not translate to a diminished client base

- Doing whatever it takes to prevent shareholders from making gains out of their investment.

etc.





<< Previous
Bullboard Posts
Next >>